Submit an online report for non-emergency incidents quickly and conveniently from any device. New resources NOW AVAILABLE! Crisis response, prevention, and intervention. Call 9-1-1 in …

ergence of lamivudine-resistant HBV variants associated with lamivudine-containing antiretroviral regimens has been reported. If DOVATO is used in patients co-infected with HIV-1 and HBV, …

DOVATO, a two-drug combination of dolutegravir (integrase strand transfer inhibitor [INSTI]) and lamivudine (nucleoside analogue reverse transcriptase inhibitor [NRTI]) is indicated as a …

Dovato (dolutegravir/lamivudine) is commonly used for HIV-1. Learn more about HIV Treatment With Dovato. Dovato may also be used for other conditions as determined by your healthcare …

Jun 27, 2024 · Dispersible ABC/DTG/3TC tablets (Triumeq PD) are FDA approved for use in children weighing ≥10 kg to <25 kg. The combination tablet DTG/3TC (Dovato) is approved by …

Mar 12, 2025 · Dovato is an HIV-1 treatment medication used for adults and adolescents 12 years and older, weighing at least 55 pounds (25kg). This antiviral medication offers a simplified …

DOVATO is a complete prescription regimen to treat HIV-1 in people 12 years and older who weigh at least 55 lbs who have not received HIV-1 medicines in the past or to replace their …

Dovato ® (dolutegravir/ lamivudine) This leaflet is designed to give you a general idea of the most important things you need to know about your new medicine.

Jan 31, 2024 · DTG is a Preferred antiretroviral drug for use during pregnancy, irrespective of trimester, and for people who are trying to conceive (see Recommendations for Use of …

Dovato is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and adolescents 12 years of age and older who weigh …